16-1777164-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080861.4(SPSB3):c.1001C>T(p.Ala334Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000689 in 1,610,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080861.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPSB3 | NM_080861.4 | c.1001C>T | p.Ala334Val | missense_variant | 7/7 | ENST00000566339.6 | |
EME2 | NM_001257370.2 | c.*926G>A | 3_prime_UTR_variant | 8/8 | ENST00000568449.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPSB3 | ENST00000566339.6 | c.1001C>T | p.Ala334Val | missense_variant | 7/7 | 1 | NM_080861.4 | P1 | |
EME2 | ENST00000568449.7 | c.*926G>A | 3_prime_UTR_variant | 8/8 | 1 | NM_001257370.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152248Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000285 AC: 7AN: 245664Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 133972
GnomAD4 exome AF: 0.0000686 AC: 100AN: 1458572Hom.: 0 Cov.: 31 AF XY: 0.0000606 AC XY: 44AN XY: 725720
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152248Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2022 | The c.1001C>T (p.A334V) alteration is located in exon 7 (coding exon 6) of the SPSB3 gene. This alteration results from a C to T substitution at nucleotide position 1001, causing the alanine (A) at amino acid position 334 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at